Modern Management of Small-Cell Lung Cancer

被引：0
|
作者：
Roberta Ferraldeschi
Sofia Baka
Babita Jyoti
Corinne Faivre-Finn
Nick Thatcher
Paul Lorigan
机构：
[1] Christie Hospital NHS Foundation Trust,CRUK Department of Medical Oncology
[2] Withington,undefined
来源：
Drugs | 2007年 / 67卷
关键词：
Etoposide; Carboplatin; Clin Oncol; Small Cell Lung Cancer; Topotecan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this article, we review best standard practice for the management of small-cell lung cancer (SCLC) and indicate the likely areas of development over the next 5–10 years. A number of prognostic scores have been developed and these allow more rational decisions on treatment.
引用
收藏
页码：2135 / 2152
页数：17
相关论文
共 50 条
  • [31] FUTURE-DIRECTIONS IN THE MANAGEMENT OF SMALL-CELL LUNG-CANCER
    JOHNSON, DH
    LUNG CANCER, 1995, 12 : S71 - S75
  • [32] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Takayasu Kurata
    Isamu Okamoto
    Kenji Tamura
    Masahiro Fukuoka
    Investigational New Drugs, 2007, 25 : 499 - 504
  • [33] Management of small cell lung cancer: Recent developments for optimal care
    Raffaele Califano
    Aidalena Z. Abidin
    Rahul Peck
    Corinne Faivre-Finn
    Paul Lorigan
    Drugs, 2012, 72 (4) : 471 - 490
  • [34] Paclitaxel for relapsed small-cell lung cancer patients with idiopathic interstitial pneumonias
    Saijo, Atsuro
    Hanibuchi, Masaki
    Ogino, Hirokazu
    Otsuka, Kenji
    Goto, Hisatsugu
    Nokihara, Hiroshi
    Nishioka, Yasuhiko
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (05) : 541 - 546
  • [35] Treatment Update in Small-Cell Lung Cancer: From Limited to Extensive Disease
    Spigel, David R.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (04) : 505 - 515
  • [36] Can the standard chemotherapeutic regimen be improved upon for small-cell lung cancer?
    Psyrri, A.
    Fountzilas, G.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (07): : 360 - 361
  • [37] Prognostic Significance of Preexisting Interstitial Lung Disease in Japanese Patients With Small-Cell Lung Cancer
    Togashi, Yosuke
    Masago, Katsuhiro
    Handa, Tomohiro
    Tanizawa, Kiminobu
    Okuda, Chiyuki
    Sakamori, Yuichi
    Nagai, Hiroki
    Kim, Young Hak
    Mishima, Michiaki
    CLINICAL LUNG CANCER, 2012, 13 (04) : 304 - 311
  • [38] VINDESINE AND ETOPOSIDE CHEMOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER AND POOR PROGNOSIS
    IREDALE, JP
    HOOI, LM
    KERR, KM
    SUDLOW, MF
    WATHEN, CG
    RESPIRATION, 1991, 58 (02) : 77 - 80
  • [39] Second-line therapy for small-cell lung cancer
    Schmittel, Alexander
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (04) : 631 - 637
  • [40] Prognosis of small-cell lung cancer since the introduction of amrubicin
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Kobayashi, Masashi
    Sasada, Shinji
    Okamoto, Norio
    Tamiya, Motohiro
    Matsuura, Yuka
    Morishita, Naoko
    Uehara, Nobuko
    Matsui, Kaoru
    Kawase, Ichiro
    MEDICAL ONCOLOGY, 2011, 28 (04) : 1430 - 1435
12345